language_icon
EN
HI

Metropolis Healthcare Share price

METROPOLIS

472.2

4.45 (-0.93%)
NSE
BSE
Last updated on 23 Apr, 2026 | 15:45 IST
Today's High

477.75

Today's Low

469.55

52 Week Low

397.08

52 Week High

565.75

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Metropolis Healthcare Chart

Metropolis Healthcare Share Key Metrics

Volume
56601.00
Market Cap
9790.02 CR
LTQ@LTP
10@472.20
ATP
472.88
Var Margin
14.13 %
Circuit Range
381.35-571.95
Delivery %
53.36 %
Value
2.68 CR
ASM/GSM
No
Market Lot
1

Summary

23 Apr, 2026 | 15:45 को, Metropolis Healthcare का शेयर प्राइस आज ₹472.2 पर है, जो दिन के लिए 4.45% की -0.93 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹469.55 और ₹477.75 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹397.08 से ₹565.75 तक रही है। ट्रेडिंग गतिविधि के मामले में, Metropolis Healthcare ने 56601 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹207327768 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹47288 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 10,47220 रही। यह स्टॉक ₹381.35-571.95 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹2.68 CR है। दिन के लिए डिलीवरी परसेंटेज 53.36% रही। इसके अतिरिक्त, Metropolis Healthcare वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Metropolis Healthcare Fundamentals

View More
P/E Ratio

58.86

P/B Ratio

6.58

Div. Yield

0

Sector P/E

54.04

Sector P/B

-16.13

Sec. Div. Yield

2.25

Metropolis Healthcare Resistance and Support

Pivot 478.95

Resistance

First Resistance

484.9

Second Resistance

493.15

Third Resistance

499.1

Support

First Support

470.7

Second Support

464.75

Third Support

456.5

Metropolis Healthcare Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

48.87%

Mutual Fund

33.28%

Insurance

2.16%

Foreign Institutional Investors

10.43%

Domestic Institutional Investors

0.35%

Retail

4.91%

Others

0%

Total Promoters
MAR '26
48.87%

Metropolis Healthcare Corporate Actions

DateAgenda
2026-02-04Quarterly Results & Bonus issue

Metropolis Healthcare News

Metropolis Healthcare Limited

Metropolis Healthcare will host an Analyst / Institutional Investor Meeting on April 17, 2026, at its Global Reference Laboratory in Kurla. The event will begin with a lab tour and discussions will be based on publicly available information, ensuring no unpublished price sensitive information is shared.
Apr 13 2026 19:04:00

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Metropolis Healthcare will host an Analyst/Institutional Investor Group Meeting on April 17, 2026. The meeting, involving Nuvama Institutional Equities, will include a lab tour at the Metropolis Global Reference Laboratory in Kurla.
Apr 13 2026 19:04:00

Metropolis Healthcare Limited

Metropolis Healthcare reports ~23% YoY consolidated revenue growth for Q4 FY26. This growth is driven by a ~30% increase in B2B revenue and strong performance in the TruHealth wellness and specialty testing segments.
Apr 03 2026 13:04:00
Read More

About Metropolis Healthcare AboutThe

NSE : 9581  
BSE : 542650  
ISIN : INE112L01020  

Dr. Sushil Kanubhai Shah one of The Promoters commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai’s Hospital having Dr. Kanubhai M. Shah Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30 1981 onwards. In June 1989 upon death of Dr. Kanubhai M. Shah the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah. Prior to March 18 1995 Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis. On March 20 1995 the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah Dr. Duru Sushil Shah and Aparna S. Shah (Rajadhyaksha) as partners in the name and style of Metropolis Lab. In January 1998 Ameera Sushil Shah was inducted as an additional partner in Metropolis Lab. With effect from February 1 2002 the business of Metropolis Lab was transferred to Dr. V. K. Desai’s Hospital as a going concern. In May 2002 Dr. G. S. K. Velu and Subbulakshmi K. Velu were admitted as partners in Dr. V. K. Desai Hospitals. The name of Dr. V. K. Desai’s Hospital was changed to Metropolis Health Services in November 2002. Further in April 2003 Ameera Sushil Shah Jaswanti Kanubhai Shah Sadacharan Gomanthybabu and Gomathybabu Gomathy were admitted as partners in Metropolis Health Services.In July 2003 Metropolis Health Services was converted into a private limited company as Metropolis Health Services (India) Private Limited (“MHSIPL”) under the Companies Act 1956. The name of MHSIPL was changed to Metropolis Health Services (India) Limited (“MHSIL”) pursuant to a ‘Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company’ granted by RoC on March 1 2006. In January 2009 MHSIL amalgamated with Pathnet India Private Limited which was a wholly owned subsidiary of MHSIL. For details see “– Scheme of amalgamation between Pathnet India Private Limited and Metropolis Health Services (India) Limited Metro Home Health Services Private Limited Lister Metropolis Laboratory and Research Centre Private Limited Tripoli Path Lab Private Limited and Diwanchand Metropolis Diagnostics Services Private Limited”.Pathnet India Private Limited was incorporated at New Delhi as a private limited company under the Companies Act 1956 pursuant to the ‘Certificate of Incorporation’ granted by the Registrar of Companies N. C. T. of Delhi and Haryana on November 10 2000. The name of The Company was changed to Pathnet India Limited pursuant to a ‘Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company’ granted by RoC on July 1 2009. The name of The Company was changed to Metropolis Healthcare Limited pursuant to a ‘Fresh Certificate of Incorporation Consequent upon Change of Name’ granted by RoC on September 23 2009. Major events and milestones of The Company :2002-First major acquisition by the Company of Sudharma2004-The Company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology India)2005-The Company received accreditation from The College of American Pathologists2006-Investment by The Western India Trustee and Executor Company in the Company-Acquisition of M/s. Lister Laboratory and Research Centre Private Limited in Chennai2007-Acquisition of Desai Clinical Laboratory in Surat2008-Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore2009-Scheme of Amalgamation 20092010-Investment by Foxcreek Investment Limited in the Company2011-Acquisition of LabOne in Raipur2012-Acquisition of Micron Laboratories in Mumbai-Acquisition of subsidiary in Kenya-Acquisition of Dr. Patel Pathology Laboratory Private Limited in Nashik-Incorporation of subsidiary in Mauritius2013-Acquisition of M/s. Ekopath Center-Pathology and Cytology Division in Guwahati-Establishment of GRL in Mumbai2014-Acquisition of subsidiary in Ghana2015-Investment by CA Lotus Investments in the Company-Incorporation of subsidiary in Uganda-Incorporation of branch office in Zambia2017-Acquisition of Sanjeevani Pathology Laboratory in Rajkot2018-Public-Private partnership agreement executed with National AIDS Control Organisation Government of India-Scheme of Amalgamation 2018-Incorporation of subsidiary in Tanzania  Awards achievements and certifications :2010-The Company was awarded the “Diagnostic Services Company of the Year” by Frost & Sullivan2012-The Company was felicitated for providing “Outstanding Quality Diagnostic Services” by HIV Congress 20122014-The Company was awarded the “Most Promising Brand” by the World Consulting and Research Corporation-The Company was awarded as a “Quality Brand” by Quality Brands India2015-The Company was awarded the “Best Diagnostic Company of the Year” at the National Awards for Excellence in Healthcare 2015-The Company was awarded the “Diagnostic Services Company of the Year” by the VCCircle Network-The Company was awarded for “Excellence in Productive Employment Creation” by Business Today2018-The Company was awarded for “Best in Health and Fitness” in the Digital Campaign Awards by LH Insights-The Company was awarded for “Excellence in Customer Service & Delivery” by Biotrains-The Company was awarded special jury mention for “Service Excellence (Diagnostic Centre)” by FICCI at the Healthcare Excellence Awards2018-2019-The Company was awarded “Iconic Pathology Lab Mumbai” by Midday Health & Wellness Icons

Read More

Metropolis Healthcare Management

NamePosition
Sushil ShahChairman Emeritus
Ameera ShahChairperson
View More

Metropolis Healthcare FAQs

Metropolis Healthcare शेयर का खरीद मूल्य 472.2 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Metropolis Healthcare शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Metropolis Healthcare शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 58.86 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Metropolis Healthcare शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 6.58 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Metropolis Healthcare शेयर का प्राइस-टू-बुक (पी/बी) रेशियो -16.13 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Metropolis Healthcare का मार्केट कैप 9790.02 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Metropolis Healthcare शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 565.75 और 397.08 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost